Transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	O
,	O
cell	O
density	O
and	O
lipopolysaccharide	O
levels	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	B:C3887640
,	O
cell	O
density	O
and	O
lipopolysaccharide	O
levels	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	O
,	O
cell	O
density	O
and	O
lipopolysaccharide	B:C0023810
levels	O
in	O
experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	O
,	O
cell	O
density	O
and	O
lipopolysaccharide	O
levels	O
in	O
experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
is	O
considered	O
a	O
valid	O
experimental	I:C0086272
model	I:C0086272
for	O
multiple	O
sclerosis	I:C0026769
,	O
a	O
chronic	O
neuroinflammatory	I:C0021368
condition	I:C0021368
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
Experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
is	O
considered	O
a	O
valid	O
experimental	I:C0086272
model	I:C0086272
for	O
multiple	O
sclerosis	I:C0026769
,	O
a	O
chronic	O
neuroinflammatory	I:C0021368
condition	I:C0021368
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
is	O
considered	O
a	O
valid	B:C0086272
experimental	I:C0086272
model	I:C0086272
for	O
multiple	O
sclerosis	I:C0026769
,	O
a	O
chronic	O
neuroinflammatory	I:C0021368
condition	I:C0021368
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
is	O
considered	O
a	O
valid	O
experimental	I:C0086272
model	I:C0086272
for	O
multiple	B:C0026769
sclerosis	I:C0026769
,	O
a	O
chronic	O
neuroinflammatory	I:C0021368
condition	I:C0021368
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
is	O
considered	O
a	O
valid	O
experimental	I:C0086272
model	I:C0086272
for	O
multiple	O
sclerosis	I:C0026769
,	O
a	O
chronic	B:C0021368
neuroinflammatory	I:C0021368
condition	I:C0021368
of	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
(	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
)	O
is	O
considered	O
a	O
valid	O
experimental	I:C0086272
model	I:C0086272
for	O
multiple	O
sclerosis	I:C0026769
,	O
a	O
chronic	O
neuroinflammatory	I:C0021368
condition	I:C0021368
of	O
the	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
.	O

Additionally	O
,	O
some	O
evidence	O
has	O
shown	O
that	O
some	O
microbial	O
products	O
such	O
as	O
the	O
bacterial	B:C0023810
lipopolysaccharide	I:C0023810
could	O
lead	O
to	O
the	O
activation	O
of	I:C1155000
reactive	I:C1155000
immune	I:C1155000
cells	I:C1155000
,	O
triggering	O
neuroinflammation	O
.	O

Additionally	O
,	O
some	O
evidence	O
has	O
shown	O
that	O
some	O
microbial	O
products	O
such	O
as	O
the	O
bacterial	O
lipopolysaccharide	I:C0023810
could	O
lead	O
to	O
the	O
activation	B:C1155000
of	I:C1155000
reactive	I:C1155000
immune	I:C1155000
cells	I:C1155000
,	O
triggering	O
neuroinflammation	O
.	O

Additionally	O
,	O
some	O
evidence	O
has	O
shown	O
that	O
some	O
microbial	O
products	O
such	O
as	O
the	O
bacterial	O
lipopolysaccharide	I:C0023810
could	O
lead	O
to	O
the	O
activation	O
of	I:C1155000
reactive	I:C1155000
immune	I:C1155000
cells	I:C1155000
,	O
triggering	B:C0032930
neuroinflammation	O
.	O

Additionally	O
,	O
some	O
evidence	O
has	O
shown	O
that	O
some	O
microbial	O
products	O
such	O
as	O
the	O
bacterial	O
lipopolysaccharide	I:C0023810
could	O
lead	O
to	O
the	O
activation	O
of	I:C1155000
reactive	I:C1155000
immune	I:C1155000
cells	I:C1155000
,	O
triggering	O
neuroinflammation	B:C0021368
.	O

Several	O
studies	B:C2603343
have	O
found	O
that	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
(	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
)	O
may	O
exert	O
a	O
neuroprotective	O
effect	O
.	O

Several	O
studies	O
have	O
found	O
that	O
transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
(	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
)	O
may	O
exert	O
a	O
neuroprotective	O
effect	O
.	O

Several	O
studies	O
have	O
found	O
that	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
(	O
transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
)	O
may	O
exert	O
a	O
neuroprotective	O
effect	O
.	O

Several	O
studies	O
have	O
found	O
that	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
(	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
)	O
may	O
exert	B:C0015264
a	O
neuroprotective	O
effect	O
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
assess	O
the	O
effect	O
of	O
transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
on	O
the	O
neuroinflammation	O
occurring	O
in	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
assess	O
the	O
effect	O
of	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
on	O
the	O
neuroinflammation	B:C0021368
occurring	O
in	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Therefore	O
,	O
we	O
aimed	O
to	O
assess	O
the	O
effect	O
of	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
on	O
the	O
neuroinflammation	O
occurring	O
in	O
Experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

A	O
total	O
of	O
44	O
male	O
Dark	B:C0086893
Agouti	I:C0086893
rats	I:C0086893
were	O
used	O
.	O

Experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
induction	O
was	O
performed	O
administering	O
subcutaneously	O
at	O
the	O
dorsal	O
base	O
of	O
the	O
tail	O
a	O
single	O
dose	O
of	O
myelin	O
oligodendrocyte	I:C0069428
glycoprotein	I:C0069428
.	O

Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
induction	O
was	O
performed	O
administering	O
subcutaneously	O
at	O
the	O
dorsal	O
base	O
of	O
the	O
tail	O
a	O
single	O
dose	O
of	O
myelin	B:C0069428
oligodendrocyte	I:C0069428
glycoprotein	I:C0069428
.	O

Clinical	B:C4084924
evaluation	I:C4084924
of	O
motor	O
symptoms	I:C0426980
was	O
performed	O
.	O

Clinical	O
evaluation	I:C4084924
of	O
motor	B:C0426980
symptoms	I:C0426980
was	O
performed	O
.	O

Brain	O
and	O
spinal	O
cord	O
were	O
collected	O
and	O
analyzed	B:C0936012
for	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
.	O

Brain	O
and	O
spinal	O
cord	O
were	O
collected	O
and	O
analyzed	O
for	O
nitric	B:C0028128
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
.	O

Brain	O
and	O
spinal	O
cord	O
were	O
collected	O
and	O
analyzed	O
for	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	B:C0023810
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
.	O

Brain	O
and	O
spinal	O
cord	O
were	O
collected	O
and	O
analyzed	O
for	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	B:C0065054
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
.	O

We	O
also	O
carried	O
out	O
a	O
histologic	B:C0019637
exam	I:C0019637
,	O
which	O
included	O
an	O
astrocyte	O
immunostaining	O
and	O
Nissl	O
staining	I:C0487602
for	O
the	O
assessment	O
of	O
brain	O
cell	O
density	O
and	O
pyknotic	O
nuclei	I:C0007610
.	O

We	O
also	O
carried	O
out	O
a	O
histologic	O
exam	I:C0019637
,	O
which	O
included	O
an	O
astrocyte	B:C0004112
immunostaining	O
and	O
Nissl	O
staining	I:C0487602
for	O
the	O
assessment	O
of	O
brain	O
cell	O
density	O
and	O
pyknotic	O
nuclei	I:C0007610
.	O

We	O
also	O
carried	O
out	O
a	O
histologic	O
exam	I:C0019637
,	O
which	O
included	O
an	O
astrocyte	O
immunostaining	B:C0487602
and	O
Nissl	O
staining	I:C0487602
for	O
the	O
assessment	O
of	O
brain	O
cell	O
density	O
and	O
pyknotic	O
nuclei	I:C0007610
.	O

We	O
also	O
carried	O
out	O
a	O
histologic	O
exam	I:C0019637
,	O
which	O
included	O
an	O
astrocyte	O
immunostaining	O
and	O
Nissl	B:C0487602
staining	I:C0487602
for	O
the	O
assessment	O
of	O
brain	O
cell	O
density	O
and	O
pyknotic	O
nuclei	I:C0007610
.	O

We	O
also	O
carried	O
out	O
a	O
histologic	O
exam	I:C0019637
,	O
which	O
included	O
an	O
astrocyte	O
immunostaining	O
and	O
Nissl	O
staining	I:C0487602
for	O
the	O
assessment	O
of	O
brain	B:C0006104
cell	O
density	O
and	O
pyknotic	O
nuclei	I:C0007610
.	O

We	O
also	O
carried	O
out	O
a	O
histologic	O
exam	I:C0019637
,	O
which	O
included	O
an	O
astrocyte	O
immunostaining	O
and	O
Nissl	O
staining	I:C0487602
for	O
the	O
assessment	O
of	O
brain	O
cell	O
density	O
and	O
pyknotic	B:C0007610
nuclei	I:C0007610
.	O

transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
effectively	O
ameliorated	O
motor	O
impairment	O
secondary	O
to	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
effectively	O
ameliorated	O
motor	B:C0234130
impairment	O
secondary	O
to	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
effectively	O
ameliorated	O
motor	O
impairment	O
secondary	O
to	O
Experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	B:C0442797
the	O
proliferation	O
of	O
astrocytes	O
as	O
a	O
response	O
to	O
the	O
autoimmune	O
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	O
the	O
proliferation	O
of	O
astrocytes	B:C0004112
as	O
a	O
response	O
to	O
the	O
autoimmune	O
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	O
the	O
proliferation	O
of	O
astrocytes	O
as	O
a	O
response	O
to	O
the	O
autoimmune	B:C0443146
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	O
the	O
proliferation	O
of	O
astrocytes	O
as	O
a	O
response	O
to	O
the	O
autoimmune	O
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	B:C0028128
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	O
the	O
proliferation	O
of	O
astrocytes	O
as	O
a	O
response	O
to	O
the	O
autoimmune	O
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	B:C0023810
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	O
the	O
proliferation	O
of	O
astrocytes	O
as	O
a	O
response	O
to	O
the	O
autoimmune	O
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	B:C0065054
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	O
nervous	I:C3714787
system	I:C3714787
.	O

This	O
form	O
of	O
magnetic	O
field	O
was	O
capable	O
of	O
decreasing	O
the	O
proliferation	O
of	O
astrocytes	O
as	O
a	O
response	O
to	O
the	O
autoimmune	O
attack	I:C0443146
,	O
reducing	O
the	O
content	O
of	O
nitric	O
oxide	I:C0028128
,	O
bacterial	O
lipopolysaccharide	O
and	O
lipopolysaccharide	O
-	I:C0065054
binding	I:C0065054
protein	I:C0065054
in	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
.	O

Moreover	O
,	O
in	O
treated	O
animals	B:C0003062
,	O
brain	O
cell	O
density	O
was	O
improved	O
and	O
the	O
number	O
of	O
pyknotic	O
nuclei	I:C0007610
was	O
decreased	O
.	O

Moreover	O
,	O
in	O
treated	O
animals	O
,	O
brain	B:C0006104
cell	O
density	O
was	O
improved	O
and	O
the	O
number	O
of	O
pyknotic	O
nuclei	I:C0007610
was	O
decreased	O
.	O

Moreover	O
,	O
in	O
treated	O
animals	O
,	O
brain	O
cell	O
density	O
was	O
improved	B:C0184511
and	O
the	O
number	O
of	O
pyknotic	O
nuclei	I:C0007610
was	O
decreased	O
.	O

Moreover	O
,	O
in	O
treated	O
animals	O
,	O
brain	O
cell	O
density	O
was	O
improved	O
and	O
the	O
number	O
of	O
pyknotic	B:C0007610
nuclei	I:C0007610
was	O
decreased	O
.	O

Transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	O
,	O
cell	O
density	O
and	O
lipopolysaccharide	O
levels	O
in	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	B:C3887640
,	O
cell	O
density	O
and	O
lipopolysaccharide	O
levels	O
in	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	O
,	O
cell	O
density	O
and	O
lipopolysaccharide	B:C0023810
levels	O
in	O
Experimental	O
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

Transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
modifies	O
astrocytosis	O
,	O
cell	O
density	O
and	O
lipopolysaccharide	O
levels	O
in	O
Experimental	B:C0014072
autoimmune	I:C0014072
encephalomyelitis	I:C0014072
.	O

These	O
results	O
suggest	O
that	O
transcranial	B:C0436548
magnetic	I:C0436548
stimulation	I:C0436548
could	O
be	O
a	O
promising	O
treatment	I:C0087111
for	O
neuroinflammatory	O
conditions	I:C0021368
such	O
as	O
multiple	O
sclerosis	I:C0026769
.	O

These	O
results	O
suggest	O
that	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
could	O
be	O
a	O
promising	B:C0087111
treatment	I:C0087111
for	O
neuroinflammatory	O
conditions	I:C0021368
such	O
as	O
multiple	O
sclerosis	I:C0026769
.	O

These	O
results	O
suggest	O
that	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
could	O
be	O
a	O
promising	O
treatment	I:C0087111
for	O
neuroinflammatory	B:C0021368
conditions	I:C0021368
such	O
as	O
multiple	O
sclerosis	I:C0026769
.	O

These	O
results	O
suggest	O
that	O
transcranial	O
magnetic	I:C0436548
stimulation	I:C0436548
could	O
be	O
a	O
promising	O
treatment	I:C0087111
for	O
neuroinflammatory	O
conditions	I:C0021368
such	O
as	O
multiple	B:C0026769
sclerosis	I:C0026769
.	O

